ICAM1 and neoplasm: They showed that treatment with either DNA methyltransferase (DNMT) or histone deacetylase (HDAC) inhibitors could increase ICAM-1 expression on tumour ECs and thus potentiate leucocyte infiltration in two different mouse tumour models [135].